OptimizeRx Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from OptimizeRx Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $37 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 90% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$35Sales grew 75% in 3 years; of every extra $100 of sales, $35 became extra profit.
Higher than 61% of Healthcare companies in United States.
Asset Productivity Ratio
+75% / +31%In 3 years sales changed by +75% while total assets changed by +31%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
4.4×Debt due within a year is covered 4.4 times by its yearly operating cash.
Higher than 79% of Healthcare companies in United States.
Cash Cushion Ratio
−2%Debt, after subtracting cash, equals 2% of its market value (net debt).
Lower than 70% of Healthcare companies in United States.
Tangible Assets Ratio
37%Of every $100 the company owns, $37 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 90% of Healthcare companies in United States.
Tangible Net Worth Ratio
13%Of every $100 of net worth, $13 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 68% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
OptimizeRx Corporation owes $0.20 for every $1 it owns. OptimizeRx Corporation returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
37.8Investors pay $37.8 for every $1 of OptimizeRx Corporation's yearly profit, higher than 68% of Healthcare companies in United States.
P/B ratio
1.30The share price is 1.30 times OptimizeRx Corporation's book value per share, lower than 73% of Healthcare companies in United States.
Market cap
$171 MThe total market value of all of OptimizeRx Corporation's shares at today's price (share price × number of shares), smaller than 60% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$131 MWhat OptimizeRx Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$6.96Net worth divided by the number of shares. The share price of $9.08 is 1.3 times this, which is the P/B above.
Return on equity (ROE)
3.7%OptimizeRx Corporation earned 3.7% on its shareholders' money over the last year, higher than 79% of Healthcare companies in United States.
Owes vs Owns
0.20×OptimizeRx Corporation owes $0.20 for every $1 it owns (low), lower than 72% of Healthcare companies in United States.
Dividend yield
NoneOptimizeRx Corporation does not currently pay a dividend.
Revenue growth
+19%Revenue rose 19% in the year to Dec 2025, and grew 21% a year on average over 3 years.
Profit growth
Back to profitOptimizeRx Corporation returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
4.7%OptimizeRx Corporation keeps $5 of every $100 of revenue as net profit.
Cash quality
3.6×Cash from OptimizeRx Corporation's business was 3.6× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
2.3×OptimizeRx Corporation's operating profit covered its interest costs 2.3 times in the year to Dec 2025.
Cash vs debt
Net debtOptimizeRx Corporation had $3 M more debt than cash (net debt) at Dec 2025.
Questions
What is OptimizeRx Corporation's P/E ratio?
Investors pay $37.8 for every $1 of OptimizeRx Corporation's yearly profit, higher than 68% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For OptimizeRx Corporation: $171 M ÷ $131 M (30 Jun 2026) = 1.3.
What is OptimizeRx Corporation's return on equity?
OptimizeRx Corporation earned 3.7% on its shareholders' money over the last year, higher than 79% of Healthcare companies in United States.
How much does OptimizeRx Corporation owe compared with what it owns?
OptimizeRx Corporation owes $0.20 for every $1 it owns (low), lower than 72% of Healthcare companies in United States.
Does OptimizeRx Corporation pay a dividend?
No. OptimizeRx Corporation does not currently pay a dividend.
Is OptimizeRx Corporation's revenue growing?
Revenue rose 19% in the year to Dec 2025, and grew 21% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.